NCT04561661

Brief Summary

This study aims at investigating if splinting and early mobilization is a better method, regarding range of motion, for treating fractures of the base phalanx of the fingers compared to surgery with pinning. This will be achieved through a randomised clinical trial comparing the two methods.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
7mo left

Started Mar 2021

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress90%
Mar 2021Dec 2026

First Submitted

Initial submission to the registry

September 14, 2020

Completed
9 days until next milestone

First Posted

Study publicly available on registry

September 23, 2020

Completed
5 months until next milestone

Study Start

First participant enrolled

March 3, 2021

Completed
5.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2026

Last Updated

June 3, 2025

Status Verified

June 1, 2025

Enrollment Period

5.8 years

First QC Date

September 14, 2020

Last Update Submit

June 1, 2025

Conditions

Outcome Measures

Primary Outcomes (4)

  • TAM (Total active range of motion)

    Total active range of motion measured in degrees of the affected finger.

    3 months

  • TAM (Total active range of motion)

    Total active range of motion measured in degrees of the affected finger.

    6 months

  • TAM (Total active range of motion)

    Total active range of motion measured in degrees of the affected finger.

    1 year

  • TAM (Total active range of motion)

    Total active range of motion measured in degrees of the affected finger.

    3 years

Secondary Outcomes (6)

  • Number of sick days

    3 months

  • Patient related outcome measure DASH

    3, 6 months and 1 and 3 years

  • Patient related outcome measure HADS

    3, 6 months and 1 and 3 years

  • Patient related outcome measure EQ-5D

    3, 6 months and 1 and 3 years

  • Patient related outcome measure HQ-8

    3, 6 months and 1 and 3 years

  • +1 more secondary outcomes

Study Arms (2)

Conservative treatment

ACTIVE COMPARATOR

Fracture treated with closed reduction, custom made orthosis and early mobilization.

Procedure: Conservative treatment

Surgery

ACTIVE COMPARATOR

Fractures treated with closed reduction, percutaneous pinning (k-wires) and plaster.

Procedure: Percutaneous pinning

Interventions

Closed reduction, percutaneous pinning and plaster

Surgery

Closed reduction, custom made orthosis and early mobilization

Conservative treatment

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Fractures of the base phalanx of digit 2-5 in the hand.

You may not qualify if:

  • Fracture older than 2 weeks.
  • More than 25° of sagittal plane and/or 10° lateral angulation after reposition.
  • Intra-articular step \>1mm.
  • Associated fractures in other bones (i e metacarpals, middle and distal phalanges) and/or tendon and nerve injuries in any finger.
  • Open fractures.
  • Patient age \<18 years.
  • Inability to co-operate with the follow-up protocol (i.e. language difficulties, severe psychiatric disorder, cognitive impairment, drug addiction).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Dept Hand Surgery

Stockholm, Sweden

RECRUITING

MeSH Terms

Conditions

Hand Injuries

Interventions

Conservative Treatment

Condition Hierarchy (Ancestors)

Wounds and Injuries

Intervention Hierarchy (Ancestors)

Therapeutics

Study Officials

  • Johanna von Kieseritzky, MD PhD

    Karolinska Institutet

    STUDY DIRECTOR

Central Study Contacts

Henrik Alfort, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Randomized controlled clinical trial
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD, Phd, Associate prof

Study Record Dates

First Submitted

September 14, 2020

First Posted

September 23, 2020

Study Start

March 3, 2021

Primary Completion (Estimated)

December 1, 2026

Study Completion (Estimated)

December 1, 2026

Last Updated

June 3, 2025

Record last verified: 2025-06

Data Sharing

IPD Sharing
Will not share

Locations